Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Holding IKT?
Track your performance easily

Inhibikase Therapeutics (IKT) Ownership - Who Owns Inhibikase Therapeutics?

123 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 23, 2024
Amit Munshi
Director
xxxxxxxxxxxxx
$500050
Oct 23, 2024
xxxxxxxxxxxxx
$2000200
Oct 23, 2024
Kush Arvind
Director
xxxxxxxxxxxxx
$198650

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,335,433Insider71.48%12,911,748
1,460,000Insider19.56%3,533,200
365,000Insider4.89%883,300
145,000Insider1.94%350,900
27,498Institution0.37%66,545
16,724Institution0.22%40,472
16,724Institution0.22%40,472
11,000Institution0.15%26,620

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
27,498Institution0.37%66,545
16,724Institution0.22%40,472
11,000Institution0.15%26,620

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
16,724Institution0.02%21,741

FAQ

Who Owns Inhibikase Therapeutics (IKT)?
Currently, no data Available
What percentage of Inhibikase Therapeutics (IKT) stock is held by institutional investors?
Currently, no data Available
What percentage of Inhibikase Therapeutics (IKT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Inhibikase Therapeutics (IKT)?
Milton H. Werner owns the most shares of Inhibikase Therapeutics (IKT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis